Torren Management’s Biogen BIIB Stock Holding History

Torren Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-107	Closed	-$18.8K	–	1050
2025 Q4	$18.8K	Buy	+107	New	+$17.5K	0.01%	596

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Torren Management's BIIB Position: Q1 2026 in Review

Torren Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 107 shares — an estimated $18.8K sold.

Torren Management first reported a position in BIIB in Q4 2025 and held it in 1 quarter. The position peaked at $18.8K in Q4 2025. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Torren Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
Torren Management sold 107 Biogen shares in Q1 2026, an estimated $18.8K.
Torren Management first reported a position in Biogen in Q4 2025 and held it in 1 quarter.
Torren Management's Biogen position peaked at $18.8K in Q4 2025.
1,008 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.